@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP748790.RAOSj0PVY6AExwZO4qg-wAqzvtTtOxvbm-BqvEyBdOKzU130_head { this: np:hasAssertion dgn-np:NP748790.RAOSj0PVY6AExwZO4qg-wAqzvtTtOxvbm-BqvEyBdOKzU130_assertion; np:hasProvenance dgn-np:NP748790.RAOSj0PVY6AExwZO4qg-wAqzvtTtOxvbm-BqvEyBdOKzU130_provenance; np:hasPublicationInfo dgn-np:NP748790.RAOSj0PVY6AExwZO4qg-wAqzvtTtOxvbm-BqvEyBdOKzU130_publicationInfo; a np:Nanopublication . dgn-np:NP748790.RAOSj0PVY6AExwZO4qg-wAqzvtTtOxvbm-BqvEyBdOKzU130_assertion a np:Assertion . dgn-np:NP748790.RAOSj0PVY6AExwZO4qg-wAqzvtTtOxvbm-BqvEyBdOKzU130_provenance a np:Provenance . dgn-np:NP748790.RAOSj0PVY6AExwZO4qg-wAqzvtTtOxvbm-BqvEyBdOKzU130_publicationInfo a np:PublicationInfo . } dgn-np:NP748790.RAOSj0PVY6AExwZO4qg-wAqzvtTtOxvbm-BqvEyBdOKzU130_assertion { miriam-gene:7145 a ncit:C16612 . lld:C0017636 a ncit:C7057 . dgn-gda:DGNb9d4466a077a3e206a46b19556c46732 sio:SIO_000628 miriam-gene:7145, lld:C0017636; a sio:SIO_001121 . } dgn-np:NP748790.RAOSj0PVY6AExwZO4qg-wAqzvtTtOxvbm-BqvEyBdOKzU130_provenance { dgn-np:NP748790.RAOSj0PVY6AExwZO4qg-wAqzvtTtOxvbm-BqvEyBdOKzU130_assertion dcterms:description "[In this study, we evaluated the genetic status of 32 glioblastomas by comparative genomic hybridization; the sensitivity of comparative genomic hybridization versus differential polymerase chain reaction to detect deletions at the phosphatase and tensin homologue deleted in chromosome 10, deleted in malignant brain tumors-1, and cyclin-dependent kinase inhibitor 2A loci and amplifications at the cyclin-dependent kinase 4 locus; the frequency of genetic lesions (gain or loss) at 16 different selected loci (including oncogenes, tumor-suppressor genes, and proliferation markers) mapping on 13 different chromosomes; and the possible existence of a statistical association between any pair of molecular markers studied, to subdivide the glioblastoma entity molecularly.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:12503074; prov:wasDerivedFrom dgn-void:befree-20150227; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20150227 pav:importedOn "2015-02-27"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP748790.RAOSj0PVY6AExwZO4qg-wAqzvtTtOxvbm-BqvEyBdOKzU130_publicationInfo { this: dcterms:created "2015-08-25T14:45:11+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v3.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v3.0.0" . }